• AgoraVox sur Twitter
  • RSS
  • Agoravox TV Mobile


Commentaire de CoolDude

sur L'ivermectine, utilisée en Inde avec succès, confirmée comme traitement Covid par la Haute Cour de Bombay


Voir l'intégralité des commentaires de cet article

CoolDude 8 juin 17:32

@Vulpes vulpes

Vous oubliez la dernière Dinesh et al., Journal of the Association of Physicians of India (Peer Reviewed).

https://www.japi.org/x284d434/hydroxychloroquine-for-sars-cov2-prophylaxis-in-healthcare-workers-ndash-a-multicentric-cohort-study-assessing-effectiveness-and-safety

Prophylaxis study with 2,727 Indian healthcare workers, showing lower risk of COVID-19 cases with treatment, and increasingly lower risk for longer durations of HCQ prophylaxis.

Risk of COVID-19 case, 60.1% lower, RR 0.40, p < 0.001, treatment 247 of 617 (40.0%), control 611 of 1473 (41.5%), adjusted per study, odds ratio converted to relative risk, >=6 weeks, logistic regression.


Risk of COVID-19 case, 35.1% lower, RR 0.65, p < 0.001, treatment 88 of 185 (47.6%), control 611 of 1473 (41.5%), adjusted per study, odds ratio converted to relative risk, 4-5 weeks, logistic regression.


Risk of COVID-19 case, 23.2% lower, RR 0.77, p = 0.002, treatment 80 of 181 (44.2%), control 611 of 1473 (41.5%), adjusted per study, odds ratio converted to relative risk, 2-3 weeks, logistic regression.




Voir ce commentaire dans son contexte





Palmarès